Today, Covetrus (NASDAQ:CVET) celebrates the combination of two unique and complementary businesses - Henry Schein Animal Health and Vets First Choice - as a newly formed company. Covetrus will leverage decades-long experience, insights, technology and global scale to empower veterinarians to enhance clinical and practice health. This means providing veterinary practices with a more comprehensive set of integrated services and technology solutions, tools to strengthen client relationships and grow their practice, while driving improved workflow and cost-effectiveness through efficient delivery of next-generation solutions.

Following the completion of the merger on February 7, today's announcement marks the launch of Covetrus, which begins regular-way trading on the Nasdaq Stock Market under the symbol CVET this morning.

President and Chief Executive Officer Benjamin Shaw, joined by members of the company's management team, will celebrate the company's first day of trading by visiting the exchange and ringing the opening bell at Nasdaq.

"Today marks an important new chapter in the world of veterinary medicine, as we launch Covetrus as a new company listed on Nasdaq," said Mr. Shaw. "We look forward to strengthening our customer relationships and expanding our veterinary practice partnerships worldwide as we bring more comprehensive and powerful solutions to market to meet their evolving needs and improve health and financial outcomes."

More information about the transactions can be found on our Registration Statement Form S-4/S-1 at sec.gov, at http://www.covetrus.com/investors/sec-filings and at this link to our fact sheet.